eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.30
+0.09 (1.25%)
At close: Mar 13, 2026, 4:00 PM EDT
7.37
+0.07 (0.96%)
After-hours: Mar 13, 2026, 4:04 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $61.23 million as of March 13, 2026. Its market cap has decreased by -53.94% in one year.
Market Cap
61.23M
Enterprise Value
57.45M
1-Year Change
-53.94%
Ranking
Category
Stock Price
$7.30
Market Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $61.23M, a decrease of -12.91%. That is a compound annual growth rate of -9.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 61.32M | -32.92% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grace Therapeutics | 62.82M |
| Alterity Therapeutics | 61.71M |
| Mereo BioPharma Group | 61.57M |
| MindWalk Holdings | 61.17M |
| Entera Bio | 60.53M |
| Impact BioMedical | 60.39M |
| Instil Bio | 59.34M |
| Actuate Therapeutics | 59.27M |